Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.9T | 2.0T | 1.3T | 1.8T |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 500.7B | 717.4B | 293.1B | 328.8B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 217.7B | 747.1B | 257.7B | 629.4B |
| Tax provision | 71.7B | 78.6B | 89.7B | 220.4B |
| Net income | 146.0B | 668.4B | 167.9B | 409.0B |
| Basic EPS | 90.9 | 360.5 | 113.6 | 276.5 |
| Diluted EPS | 90.9 | 360.5 | 113.6 | 276.5 |
| Basic average shares | 1.6B | 1.6B | 1.5B | 1.5B |
| Diluted average shares | 1.6B | 1.6B | 1.5B | 1.5B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | 747.1B | — | — |
| Minority interests | -48M | 26.7M | 28.5M | -60M |
| Preferred stock dividends | — | — | — | — |